[1]
M. Ayutri, R. Andrajati, and A. Subhan, “EVALUATION OF OSELTAMIVIR AND FAVIPIRAVIR ON CLINICAL OUTCOMES AND LENGTH OF STAY IN COVID-19 PATIENTS AT FATMAWATI GENERAL HOSPITAL JAKARTA”, Asian J Pharm Clin Res, vol. 15, no. 10, pp. 84–86, Oct. 2022.